A Safe Selection March 4, 2015 Actavis (ACT) is one of my safest selections for client portfolios, here’s why. Read More »
Actavis & Allergan Can Make $25 in 2017 December 16, 2014 Actavis (ACT) acquired Allergan (AGN) and now could make $25 in 2017. Read More »
Growth Slowing in Q4 August 29, 2014 Actavis (ACT) had 70% profit growth last quarter, but ACT’s growth will slow by the fourth quarter. Read More »
The Time of Its Life June 5, 2014 Actavis (ACT) is haing the time of its life right now, and I’ll be adding ACT to the Growth Portfolio today. Read More »